Oral Sol. Laclose 3.35 gm / 5 ml information and price in Bangladesh

Information: Oral Sol. Laclose 3.35 gm / 5 ml

Therapeutic action – Osmotic laxative Indications – Prevention of constipation in patients taking opioid analgesics (e.g. codeine, morphine) Presentation – 10 g/15 ml oral solution Dosage and duration – Child under 1 year: 5 ml/day (1 tsp/day) – Child from 1 to 6 years: 5 to 10 ml/day (1 to 2 tsp/day) – Child from 7 to 14 years: 10 to 15 ml/day (2 tsp/day or 1 ssp/day) – Child over 14 years and adult: 15 to 45 ml/day (1 to 3 ssp/day) Start lacLACLOSEe when analgesic treatment continues more than 48 hours. LacLACLOSEe must be taken daily, until the end of the opioid treatment. Regular follow up (frequency/consistency of stools) is essential in order to adjust dosage correctly. Contra-indications, adverse effects, precautions – Do not administer to patients with Crohn’s disease, ulcerative colitis, intestinal obstruction, undiagnosed abdominal pain. – May cause: abdominal discomfort, flatulence and diarrhoea. – In the event of diarrhoea, exclude a faecal impaction and intestinal obstruction; reduce the dose. – Pregnancy: no contra-indication – Breast-feeding: no contra-indication Remarks – It may take up to 48 hours, or even longer, before the treatment is effective. LacLACLOSEe is not indicated in acute constipation where a rapid result is needed. – If necessary, lacLACLOSEe may be given in combination with a stimulant laxative (e.g. bisacodyl, senna). – The oral solution may be taken undiluted, or diluted in water. – The treatment should be accompanied by dietary measures (fluids and fibre). – Storage: below 25°C. Do not store in a refrigerator (cristallisation). http://www.opsonin-pharma.com/product-details.php?pid=80 https://medlineplus.gov/druginfo/meds/a682338.html https://en.wikipedia.org/wiki/LacLACLOSEe

Caution: Oral Sol. Laclose 3.35 gm / 5 ml

Before taking Oral Sol. Laclose 3.35 gm / 5 ml, inform your doctor if you or your child have liver or kidney problems or any allergies. It should be used with caution in patients with liver problems due to alcohol to prevent the risk of liver damage.

Oral Sol. Laclose 3.35 gm / 5 ml should be used with caution in pregnant women only if clearly advised by the doctor and can be used in breastfeeding women.

Oral Sol. Laclose 3.35 gm / 5 ml is not recommended for use in children less than 10 years of age and should be used with caution in elderly patients.

Consult your doctor if you experience any side effects or unusual effects during treatment with Oral Sol. Laclose 3.35 gm / 5 ml.

Safety: Oral Sol. Laclose 3.35 gm / 5 ml

It is unsafe to consume alcohol with Oral Sol. Laclose 3.35 gm / 5 ml